This forum thread continues to gain traction among AJP readers: “If the main manufacturers of low-dose Codeine don’t see a market and the generics come to the same conclusion, then what will happen to those for whom low-dose codeine was all they needed? Yes there is Paracetamol+Ibuprofen (P+I), (don’t have an ulcer/crook liver), but even for prescribers there will be no in between P+I and Panadeine Forte if the all low-dose Codeine options are gone.
“Also what person with temporary but acute pain that may have been happy with low-dose Codeine is going to be satisfied after spending the time & money to see a doctor to walk away with a low-dose instead of high dose Panadeine script? Another reason there will be no market for low-dose Codeine come 1 Feb 2018.”
- Who’s going to use MedsASSIST post Feb 1st?
- Meningococcal vaccine
- Medication review
- HMR claims
- Pharmacy employment in Queensland
Click here to visit the AJP Discussion Forum.
Haven’t registered yet? Click here.
…..the elephant in the room is the idea that 8mg codeine combinations were sub therapeutic anyway……
The pollster has forgotten a major concern: the potential lack of support for codeine abusers, including extra funding for Opioid Substitution Therapy and access to Drug and Alcohol specialists.